EARLY GENES AND KINDLING DEVELOPMENT
EARLY GENES AND KINDLING DEVELOPMENT
批准号:
3084675
负责人:
JAMES R BURKE
金额:
$8.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-01 至 1996-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Epilepsy is a common neurologic disorder afflicting over two million
people in the United States. More than 25% of patients with epilepsy
continue to have seizures despite optimal therapy with conventional
drugs. Kindling is an animal model of complex partial epilepsy (CPE),
the adult seizure type that is most common and often refractory to
treatment.
Kindling refers to a phenomenon in which repeated, focal application of
initially subconvulsive electrical stimulations to the brain eventually
results in seizure. Each stimulation must evoke an electrographic
seizure (afterdischarge (AD)). Moreover, activation of a subtype of
excitatory amino acid receptor, the N-methyl-D-aspartate (NMDA) receptor,
during AD is required for kindling to develop. How these transient
events generate the long lasting enhanced neuronal excitability is not
known.
The recent discovery that AD and NMDA receptor activation can trigger
increases in c-fos, an immediate early gene (IEG), has been shown to
alter the expression of other genes (target genes) by acting as a
transcriptional regulator. It is hypothesized that c-fos expression
activates target genes which are necessary for the persistent state of
neuronal excitability known as kindling. To facilitate testing this
hypothesis, we have begun to study the earliest events in kindling
development. We showed that a lasting increase in AD duration occurs
after only 2 brief stimulation-evoked ADs. We have also demonstrated
that AD-evoked c-fos expression occurs in a highly specific pattern
uniformly involving the medial amygdaloid nucleus.
Initial attempts to test this hypothesis will be performed by blocking
transcription and translation of c-fos following AD. Additional
experiments will specifically interfere with second messenger systems
involved in c-fos induction. Candidate compounds for blocking NMDA-
induced c-fos expression will be tested in primary neuronal culture
derived from rat dentate gyrus. Those found effective will then be
examined for their effect on c-fos expression and increase in AD duration
in vivo. The results of these experiments should increase our
understanding of the mechanism underlying the development of kindling.
The ultimate goal of this line of investigation is to extend the
anticipated findings to human CPE, thereby facilitating better
understanding and treatment of seizures in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
QBP1 Mimetics as Therapeutics for Huntington's Disease
-
批准号:6788916
-
项目类别:
-
资助金额:$18.8万
-
财政年份:2004
-
负责人:JAMES R BURKE
-
依托单位:
MANIPULATION OF POLYGLUTAMINE-PROTEIN INTERACTIONS
-
批准号:6394530
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2000
-
负责人:JAMES R BURKE
-
依托单位:
MANIPULATION OF POLYGLUTAMINE-PROTEIN INTERACTIONS
-
批准号:6454936
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2000
-
负责人:JAMES R BURKE
-
依托单位:
MANIPULATION OF POLYGLUTAMINE-PROTEIN INTERACTIONS
-
批准号:6484937
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2000
-
负责人:JAMES R BURKE
-
依托单位:
MANIPULATION OF POLYGLUTAMINE-PROTEIN INTERACTIONS
-
批准号:6194419
-
项目类别:
-
资助金额:$26.36万
-
财政年份:2000
-
负责人:JAMES R BURKE
-
依托单位:
MANIPULATION OF POLYGLUTAMINE-PROTEIN INTERACTIONS
-
批准号:6540341
-
项目类别:
-
资助金额:$26.95万
-
财政年份:2000
-
负责人:JAMES R BURKE
-
依托单位:
NMR STUDIES OF NAD BOUND TO UDP-GALACTOSE 4-EPIMERASE
-
批准号:3045934
-
项目类别:
-
资助金额:$1.43万
-
财政年份:1993
-
负责人:JAMES R BURKE
-
依托单位:
NMR STUDIES OF NAD BOUND TO UDP-GALACTOSE 4-EPIMERASE
-
批准号:3045933
-
项目类别:
-
资助金额:$2.27万
-
财政年份:1992
-
负责人:JAMES R BURKE
-
依托单位:
NMR STUDIES OF NAD BOUND TO UDP-GALACTOSE 4-EPIMERASE
-
批准号:3045932
-
项目类别:
-
资助金额:$2.16万
-
财政年份:1991
-
负责人:JAMES R BURKE
-
依托单位:
EARLY GENES AND KINDLING DEVELOPMENT
-
批准号:2259432
-
项目类别:
-
资助金额:$8.82万
-
财政年份:1991
-
负责人:JAMES R BURKE
-
依托单位:
EARLY GENES AND KINDLING DEVELOPMENT
-
批准号:3084673
-
项目类别:
-
资助金额:$7.68万
-
财政年份:1991
-
负责人:JAMES R BURKE
-
依托单位:
EARLY GENES AND KINDLING DEVELOPMENT
-
批准号:3084674
-
项目类别:
-
资助金额:$8.78万
-
财政年份:1991
-
负责人:JAMES R BURKE
-
依托单位:
EARLY GENES AND KINDLING DEVELOPMENT
-
批准号:2259433
-
项目类别:
-
资助金额:$7.62万
-
财政年份:1991
-
负责人:JAMES R BURKE
-
依托单位:
CLINICAL RESEARCH DEVELOPMENT CORE
-
批准号:8100406
-
项目类别:
-
资助金额:$69.12万
-
财政年份:--
-
负责人:JAMES R BURKE
-
依托单位:
CLINICAL RESEARCH DEVELOPMENT CORE
-
批准号:7459866
-
项目类别:
-
资助金额:$62.33万
-
财政年份:--
-
负责人:JAMES R BURKE
-
依托单位:
CLINICAL RESEARCH DEVELOPMENT CORE
-
批准号:7925610
-
项目类别:
-
资助金额:$67.78万
-
财政年份:--
-
负责人:JAMES R BURKE
-
依托单位:
CLINICAL RESEARCH DEVELOPMENT CORE
-
批准号:7647082
-
项目类别:
-
资助金额:$62.92万
-
财政年份:--
-
负责人:JAMES R BURKE
-
依托单位:
海外基金